[6-K] PolyPid Ltd. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

PolyPid Ltd. submitted a Form 6-K dated August 13, 2025, furnishing its unaudited interim condensed financial statements and management's discussion and analysis for the six months ended June 30, 2025. The filing includes XBRL-formatted financial information covering interim condensed consolidated balance sheets, statements of operations, shareholders' equity, cash flows and notes, plus an embedded Cover Page Interactive Data File. The report is submitted by the Chief Executive Officer and lists related exhibit numbers for the financial statements, MD&A and XBRL tagging.

Positive

• Unaudited interim condensed financial statements for the six months ended June 30, 2025 are furnished
• Management's Discussion and Analysis (MD&A) for the six months ended June 30, 2025 is included
• XBRL-formatted financial information (balance sheets, operations, equity, cash flows, notes) is provided
• Cover Page Interactive Data File is embedded to improve accessibility

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine Form 6-K furnishing interim financials and MD&A; provides XBRL data for investor review.

The filing is a standard disclosure delivering PolyPid's unaudited interim condensed financial statements and accompanying MD&A for the six-month period ended June 30, 2025. The inclusion of XBRL-tagged financials and an embedded interactive cover page improves accessibility and machine-readability of the financial data. There are no operational metrics, earnings figures or transaction details in the excerpt provided, so material financial conclusions cannot be drawn from this text alone.

Corporate Governance Expert

TL;DR: Corporate disclosure appears compliant and appropriately executed for a Form 6-K submission.

The document lists exhibits and confirms submission by the Chief Executive Officer, consistent with routine reporting practices for a foreign issuer furnishing interim results. The filing references XBRL formatting and the MD&A, which supports transparency. The excerpt contains no governance actions, leadership changes, or material transactions to assess beyond disclosure completeness.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of: August 2025 (Report No. 3)

Commission File Number: 001-38428

PolyPid Ltd.

(Translation of registrant’s name into English)

18 Hasivim Street

Petach Tikva 495376, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F      ☐ Form 40-F

CONTENTS

This Report of Foreign Private Issuer on Form 6-K consists of PolyPid Ltd.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements as of June 30, 2025, which is attached hereto as Exhibit 99.1; and (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025, which is attached hereto as Exhibit 99.2.

The contents of this Form 6-K are incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-276826, File No. 333-280658, File No. 333-281863, File No. 333-284376 and File No. 333-289034) and Form S-8 (File No. 333-239517, File No. 333-271060, File No. 333-277703, File No. 333-280662 and File No. 333-289570) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

1

EXHIBIT INDEX

Exhibit No.
99.1		PolyPid Ltd.’s Unaudited Interim Condensed Financial Statements as of June 30, 2025.
99.2		PolyPid Ltd.’s Management’s Discussion and Analysis of Financial Condition and Results of Operation for the Six Months Ended June 30, 2025.
101		The following financial information from the Registrant’s Unaudited Interim Condensed Financial Statements as of June 30, 2025, formatted in XBRL (eXtensible Business Reporting Language): (i) Interim Condensed Consolidated Balance Sheets, (ii) Interim Condensed Consolidated Statements of Operations, (iii) Interim Condensed Consolidated Statements of Shareholders’ Equity; (iv) Interim Condensed Consolidated Statements of Cash Flows, and (v) Notes to Interim Condensed Consolidated Financial Statements.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	POLYPID LTD.
Date: August 13, 2025	By:	/s/ Dikla Czaczkes Akselbrad
		Name:	Dikla Czaczkes Akselbrad
		Title:	Chief Executive Officer

3

FAQ

What did PolyPid (PYPD) file in this Form 6-K?

The company furnished its unaudited interim condensed financial statements and MD&A for the six months ended June 30, 2025, and XBRL-tagged financials.

Which financial schedules are included in the XBRL data?

The XBRL information covers interim condensed consolidated balance sheets, statements of operations, shareholders' equity, cash flows and notes.

When was the Form 6-K submitted?

The filing is dated August 13, 2025 and is presented as submitted by the Chief Executive Officer.

Does the excerpt contain actual earnings or revenue numbers?

No. The provided excerpt lists exhibits and XBRL items but does not include specific earnings, revenue or other numeric financial results.

Does this filing indicate any material transactions or governance changes?

No. The excerpt contains no information about transactions, leadership changes, or material events beyond the interim financial disclosures.